Hiroki Kato

9PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersAcceleratorsCancer diagnosisBiomedical imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Therapeutic Efficacy and Safety of Intraperitoneally Administered 211At-Labeled Gold Nanoparticles for Peritoneally Disseminated Malignancies.

|Jul 09, 2025
Potentially fatal crisis after 177Lu-DOTATATE therapy for paraganglioma: a case report with review of literature.

Aoki Tobimatsu, Kosuke Mukai, Yoshinari Obata

|Dec 23, 2022
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.

Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga

|Sep 03, 2022
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions.

Mirei Watanabe, Hiroki Kato, Daisuke Katayama

|Jul 07, 2022
Impaired neuronal integrity in traumatic brain injury detected by 123I-iomazenil single photon emission computed tomography and MRI.

Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka

|Aug 07, 2021
Evaluation of Integrin αvβ3 Expression in Murine Xenograft Models: [68Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation.

Kosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka

Pageof 2

Frequent Collaborators

2 joint publications

Xuhao Huang

2 joint publications

Kazuko Kaneda-Nakashima

1 joint publications

Hiromasa Kuroda

1 joint publications

Kosuke Mitsuyuki